导师姓名： 罗全勇 专业代码： 100207
性别： 男 专业名称： 影像医学与核医学
培养单位： 附属第六人民医院 三级学科/
专业领域：
导师类型： 博士生导师 专业学位导师： 兼
联系方式： 上海市宜山路600号 第六人民医院 核医学科.Tel：.E-mail：lqyn@sh163.net；luoqy@sjtu.edu.cn
邮编： 200233 邮箱地址： lqyn@sh163.net

研究方向 (点击浏览详细信息)
核医学在肿瘤诊治中的基础研究与临床应用

社会任职
《复旦学报（医学版）》特邀审稿专家
上海医学会核医学专科分会 治疗学组组长
上海市医师协会影像与核医学医师分会委员
上海市医学会医疗鉴定专家库成员
上海抗癌协会甲状腺癌专业委员会 委员
上海市中西医结合学会核医学分会副主任委员
《肿瘤影像学》常务编委
《Journal of Medcial Imaging and Health Informatics》Guest Editor
上海市核学会 理事
《中华核医学与分子影像学杂志》常务编委
上海市核医学质控中心专家委员会委员
中国医师协会核医学医师分会 委员
中国医学影像技术研究会 理事兼核医学分会委员
中国医疗保健国际交流促进会甲状腺疾病分会 常委
中华医学会核医学分会 治疗学组委员
中国抗癌协会肿瘤核医学专业委员会委员
上海市医学会核医学专科分会副主任委员

科研项目 项目编号项目名称课题来源起止年月批准经费承担职责
YG2019ZDA09 基于AI&18F-FDG PET/CT影像组学多维信息构建的预测碘-131难治性分化型甲状腺癌的智能诊断系统 上海交通大学‘交大之星’计划医工交叉研究基金（重点项目） 2020-01~2022-12 100万元 课题负责人
** CD146介导碘-131难治性甲状腺癌进展转移的机制及诊疗分子影像探针研制 国家自然科学基金 2020-01~2023-12 55万元 课题负责人
** miR-106a/RARB/MAPK信号轴参与PD-L1调控乳头状甲状腺癌失分化机制研究 国家自然科学基金 2018-01~2021-12 55万元 课题参与人
2017YFC** 基于云技术的PET-CT可靠性及服务体系动态评价研究 国家重点研发计划（数字诊疗装备研发专项） 2017-07~2019-12 203万元 课题参与人
** Afamin对分化型甲状腺癌失分化与碘-131摄取功能的影响及机制 国家自然科学基金 2013-01~2016-12 70万元 课题负责人
** micro-RNA106a对乳头状甲状腺癌碘-131摄取功能的影响及机制 国家自然科学基金 2013-01~2016-12 24万元 课题参与人
2010-2013 分化型甲状腺癌的碘-131治疗与蛋白质组学研究 上海交通大学医学院“新****” 2010-01~2013-12 15万元 课题负责人
06QA14040 99mTc-Annexin B1早期探测化疗后肿瘤细胞凋亡的实验研究 上海市科委启明星计划 2007-01~2008-12 10万元 课题负责人
** 99mTc-Annexin B1早期探测化疗后肿瘤细胞凋亡的实验研究 国家自然基金委 2007-01~2009-12 23万元 课题负责人

学术论文 作者论文标题期刊名出版年卷期页码
Qiu ZL, Shen CT, Sun ZK, Song HJ, Zhang GQ, Luo QY. （通讯作者） Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators Front Endocrinol 2020 10:903. doi: 10.3389/fendo.2019.00903. eCollection 2019
Wei Wj, Rosenkrans ZT, Liu J, Huang G, Luo QY （通讯作者）, Cai W ImmunoPET: Concept, Design, and Applications Chem. Rev. 2020 120, 3787?3851(IF=54.301)
Zhang GQ, Shen CT, Song HJ, Qiu ZL, Luo QY. （通讯作者） High Expression of Interleukin-12A and Its Association with the Clinicopathology and Prognosis of Differentiated Thyroid Cancer Eur Thyroid J. 2020 9(3):139-147.
Qiu ZL, Shen CT, Sun ZK, Tang J, Song HJ, Zhang GQ, Luo QY. （通讯作者） Distant metastases from pathologically proven benign follicular nodules of the thyroid: clinicopathological features and predictors of long-term survival Endocrine. 2020 69(1):113-125.
Chuang Xi, Guo-Qiang Zhang, Zhen-Kui Sun, Hong-Jun Song, Chen-Tian Shen, Xiao-Yue Chen, Jian-Wen Sun, Zhong-Ling Qiu, Quan-Yong Luo （通讯作者） Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice Front Immunol . 2020 11:1124. doi: 10.3389/fimmu.2020.01124.
Wei WJ ,Hardin H ,Luo QY （通讯作者） Targeting autophagy in thyroid cancers. Endocr Relat Cancer 2019 26（4）R181–R194（IF=4.774）
Weijun Wei, Dawei Jiang, Emily B. Ehlerding, Todd E. Barnhart, Yunan Yang,Jonathan W. Engle, Quan-Yong Luo （通讯作者）,* Peng Huang,* and Weibo Cai* CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma Advanced Science 2019 2019, 6, **(IF=15.804)
WJ Wei ZT Rosenkrans, QY Luo, XL Lan （通讯作者）, Weibo Cai Exploiting Nanomaterial-mediated Autophagy for Cancer Therapy Small Methods. 2019 13; 3(2): doi:10.1002/smtd.(IF=12.13)
Weijun Wei, Emily B. Ehlerding, Xiaoli Lan, Quanyong Luo （通讯作者）,Weibo Cai Molecular imaging of β-cells: diabetes and beyond Advanced Drug Delivery Reviews 2019 139;16–31 (IF=15.519)
Wei W, Ehlerding EB, Lan X, Luo Q （通讯作者）, Cai W. PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging. 2018 2018;45(1):132-150. (IF=7.277)
Weijun Wei, Dalong Ni, Emily B. Ehlerding, Quan-Yong Luo （通讯作者）, Weibo Cai PET imaging of receptor tyrosine kinases in cancer Molecular Cancer Therapeutics 2018 17(8):1625-1636. (IF=5.365)
Wei W, Jiang D, Ehlerding EB, Luo Q （通讯作者）, Cai W. Noninvasive PET Imaging of T cells. Trends in Cancer 2018 4(5):359-373 (IF=8.884)
Wei WJ, Zhang GQ, Luo QY （通讯作者） Postsurgical Management of Differentiated Thyroid Cancer in China. Trends Endocrinol Metab 2018 S1043-2760(17)30140-6（IF=10.89）
Qiu ZL, Wei WJ, Shen CT, Song HJ, Zhang XY, Sun ZK, Luo QY. （通讯作者） Diagnostic Performance of 18F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative 131I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb Level. Sci Rep. 2017 6;7(1):2849.(IF=4.259)
Shen CT, Qiu ZL, Sun ZK, Wei WJ, Song HJ, Zhang XY, Luo QY. （通讯作者） Dual time-point 18F-FDG PET/CT imaging with multiple metabolic parameters in the differential diagnosis of malignancy-suspected bone/joint lesions. Oncotarget. 2017 17. doi: 10.18632/oncotarget.17140.(IF=5.168)
Shen CT, Zhang XY, Qiu ZL, Sun ZK, Wei WJ, Song HJ, Luo QY. （通讯作者） Thyroid autoimmune antibodies in patients with papillary thyroid carcinoma: a double-edged sword? Endocrine 2017 2017 Oct;58(1):176-183. (IF=3.131)
Wei WJ, Sun ZK, Shen CT, Qiu ZL, Luo QY. （通讯作者） Adefovir-Induced Hypophosphatemic Osteomalacia Mimicking Bone Metastases From Primary Hepatocarcinoma. Clin Nucl Med 2017 2017;42(9):e405-e406.(IF=4.563)
Wei WJ, Sun ZK, Shen CT, Zhang XY, Tang J, Song HJ, Qiu ZL, Luo QY. （通讯作者） Value of 99mTc-MDP SPECT/CT and 18F-FDG PET/CT scanning in the evaluation of malignantly transformed fibrous dysplasia. Am J Nucl Med Mol Imaging 2017 2017;7(3):92-104.
Shen CT, Wei WJ, Qiu ZL, Song HJ, Zhang XY, Sun ZK, Luo QY. （通讯作者） Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo. J Mol Endocrinol. 2017 58(1):15-23.（IF=3.577）
Wei-Jun Wei, Zhen-Kui Sun, Chen-Tian Shen, Hong-Jun Song, Xin-Yun Zhang, Zhong-Ling Qiu, Quan-Yong Luo （通讯作者） Obatoclax and LY** Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer Theranostics 2017 7(4):987-1001. doi:10.7150/thno.17322(IF=8.854)
Chen‐Tian Shen, Yinan Zhang, Yu‐Min Liu, Shan Yin, Xin‐Yun Zhang, Wei‐Jun Wei, Zhen‐Kui Sun, Hong‐Jun Song, Zhong‐Ling Qiu, Cong‐Rong Wang, Quan‐Yong Luo （通讯作者） A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2017 2017;87(6):844-852.(IF=3.327)
Shen CT, Qiu ZL, Song HJ, Wei WJ, Luo QY. （通讯作者） miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway. J Exp Clin Cancer Res. 2016 35(1):101(IF=5.189)
Wei WJ, Shen CT, Song HJ, Qiu ZL, Luo QY. （通讯作者） Metastatic Malignant Fibrous Histiocytoma Infiltrating Sigmoid Colon: A Case Diagnosed With the Help of 18F-FDG PET/CT. Clin Nucl Med. 2016 41(4):338-40(IF=3.64)
Shen CT, Wei WJ, Qiu ZL, Song HJ, Luo QY. （通讯作者） Afamin promotes glucose metabolism in papillary thyroid carcinoma. Mol Cell Endocrinol. 2016 434:108-15(IF=3.754)
Zhong-Ling Qiu, Chen-Tian Shen, Zhen-kui Sun, Wei-Jun Wei, Xin-Yun Zhang, Hong-Jun Song, Quan-Yong Luo （通讯作者） Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting 131I Uptake and Mortality in Papillary Thyroid Cancer Patients with Lung Metastases. Cell Physiol Biochem. 2016 40:1377-1390(IF=5.104)
Wei WJ, Shen CT, Song HJ, Qiu ZL, Luo QY. （通讯作者） Propranolol sensitizes thyroid cancer cells to cytotoxic effect of vemurafenib. Oncol Rep. 2016 36(3):1576-84(IF=2.662)
Wei WJ, Shen CT, Song HJ, Qiu ZL, Luo QY （通讯作者） MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis Clin Endocrinol (Oxf). 2016 84(1):127-33(IF=3.327)
Shen CT, Qiu ZL, Han TT, Luo QY. （通讯作者） Performance of 18F-Fluoride PET or PET/CT for the Detection of Bone Metastases: A Meta-analysis. Clin Nucl Med. 2015 40(2):103-110(IF=4.278)
Qiu ZL, Shen CT, Luo QY （通讯作者） Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy Thyroid 2015 25(2):229-37(IF=3.784)
Wei WJ, Shen CT, Song HJ, Qiu ZL, Luo QY （通讯作者） Comparison of SPET/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: A meta-analysis. Hell J Nucl Med. 2015 18(2):127-35(IF=1.015)
Shen CT, Wei WJ, Qiu ZL, Song HJ, Luo QY. （通讯作者） Value of post-therapeutic 131I scintigraphy in stimulated serum thyroglobulin-negative patients with metastatic differentiated thyroid carcinoma. Endocrine. 2015 51(2):283-90(IF=3.279)
Song HJ, Qiu ZL, Shen CT, Wei WJ, Luo QY. （通讯作者） Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. European Journal of Endocrinology 2015 173(3):399–408(IF=3.892)
Qiu ZL, Shen CT, Song HJ, Wei WJ, Luo QY. （通讯作者） Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study. Nucl Med Biol. 2015 42(5):499-504. (IF=2.429)
Shen CT, Qiu ZL, Luo QY. （通讯作者） More effective agents still needed for progressive radioiodine-refractory differentiated thyroid cancer. Endocr Relat Cancer. 2014 21(2):3-4(IF=4.472)
Qiu ZL, Xue YL, Luo QY. （通讯作者） Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine. Arq Bras Endocrinol Metabol. 2014 58(3):260-269(IF=1.028)
Xue YL, Qiu ZL, Song HJ, Luo QY. （通讯作者） Large thigh muscle metastasis as an initial manifestation of follicular thyroid cancer. Clin Nucl Med 2014 39(4):363-364(IF=4.278)
Shen CT, Qiu ZL, Luo QY. （通讯作者） Efficacy and safety of selumetinib compared with current therapies for advanced cancer: a meta-analysis. Asian Pac J Cancer Prev. 2014 15(5):2369-2374
Shen CT, Qiu ZL, Han TT, Luo QY. （通讯作者） Right pulmonary artery atresia with left circumflex coronary collaterals supplying the affected lung diagnosed by V/Q scintigraphy and CTA: a case report and review of the literature. Ann Nucl Med. 2014 28(10):1027-1031(IF=1.467)
Shen CT,Qiu ZL,Luo QY. （通讯作者） Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis. Endocr Relat Cancer 2014 21(2):253-261(IF=4.472)
Qiu ZL,Wu B,Shen CT,Zhu RS,Luo QY. （通讯作者） Dual-phase (99m)Tc-MIBI scintigraphy with delayed neck and thorax SPECT/CT and bone scintigraphy in patients with primary hyperparathyroidism: correlation with clinical or pathological variables. Ann Nucl Med. 2014 28(8):725-735(IF=1.467)
Xue YL, Qiu ZL, Song HJ, Luo QY. （通讯作者） Value of 131I-SPECT/CT on Patients with Differentiated Thyroid Cancer: A Systematic Review of the Literature. Eur J Nucl Med Mol Imaging. 2013 3（3）:1-12(IF=5.537)
Qiu ZL, Wu CG, Zhu RS, Xue YL, Luo QY. （通讯作者） Unusual case of solitary functioning bone metastasis from a "parathyroid adenoma": imagiologic diagnosis and treatment with percutaneous vertebroplasty--case report and literature review. J Clin Endocrinol Metab 2013 98(9):3555-3561(IF=5.531)
Zhao CL,Qiu ZL,Chen LB,Yuan ZB,Luo QY. （通讯作者） Sustained and Diffuse I-131 Avid Bone Metastases with Low Serum Thyroglobulin Levels in a Patient with Papillary Thyroid Carcinoma Clin Nucl Med 2013 38（5）：375-377(IF=4.278)
Xue YL, Qiu ZL, Perotti G, Salvatori M, Luo QY. （通讯作者） 131I SPECT/CT: a one-station imaging modality in the management of differentiated thyroid cancer. Clinical and Translational Imaging. 2013 1(3):163-173.
Song HJ,Xue YL,Qiu ZL,Luo QY （通讯作者） Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-131I-avid lung metastases Nuclear Medicine Communications 2013 34(12):1196-1203.(IF=1.453)
Xu YH, Shen CT, Xue YL, Qiu ZL, Luo QY. （通讯作者） Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma. Hell J Nucl Med. 2013 16(3):199-203(IF=1.015)
Song HJ, Xu YH, Qiu ZL, Luo QY （通讯作者） Percutaneous osteoplasty combined with Radioiodine as a Treatment for Bone Metastases from Differentiated Thyroid Carcinoma. Clinical Nuclear Medicine 2012 37（6）：129-133(IF=4.278)
Song HJ, Xue YL, Qiu ZL, Luo QY. （通讯作者） Uncommon metastases from differentiated thyroid carcinoma. Hell J Nucl Med. 2012 15(3):233-240.(IF=1.015)
Qiu ZL, Xue YL, Song HJ, Luo QY. （通讯作者） Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Nuclear Medicine Communications 2012 33(12):1232-1242(IF=1.453)
Song HJ, Xu YH, Qiu ZL, Luo QY （通讯作者） Abnormal Iodine-131 Uptake in a Benign Serous Ovarian Cystadenoma Mimicking Bladder Physiological Uptake. Clinical Nuclear Medicine 2012 37（3）：59-60(IF=4.278)
Xu YH, Song HJ, Qiu ZL, Luo QY. （通讯作者） Serum differential proteomics analysis between papillary thyroid cancer patients with 131I-avid lung metastases and those with non-131I-avid lung metastases. Hellenic Journal of Nuclear Medicine 2011 14（3）：228-233(IF=1.015 )
Qiu ZL, Song HJ, Xu YH, Luo QY. （通讯作者） Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. Journal of Clinical Endocrinology & Metabolism 2011 96(10):3078-3086(IF=5.531)
Xu YH, Song HJ, Qiu ZL, Luo QY. （通讯作者） Brain metastases with exceptional features from papillary thyroid carcinoma：report of three cases. Hellenic Journal of Nuclear Madicine 2011 14（1）:44-48(IF=1.015 )
Song HJ, Xu YH, Qiu ZL, Luo QY. （通讯作者） Rare Metastases of Differentiated Thyroid Carcinoma: Pictorial review. Endocrine Related cancer 2011 35(3):165-174(IF=4.472)
Qiu ZL, Xu YH, Song HJ, Luo QY. 33(2):171-177. （通讯作者） Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 131I-SPECT/CT. Head and Neck 2011 33(2):171-177(IF=2.76)
Xu YH, Song HJ, Qiu ZL, Luo QY. （通讯作者） Multiply extraosseous accumulation of 99mTc-MDP in acute lymphocytic leykemia and literature review. Hellenic Journal Of Nuclear Medicine 2010 13(3):273-276(IF=1.015 )
Qiu ZL, Xu YH, Song HJ, Luo QY. （通讯作者） Unusual 131I Uptake in a Benign Mucinous Cystadenoma of the Ovary in a Patient with Papillary Thyroid Cancer. Clinical Nuclear Medicine 2010 35(12):965-966(IF=4.278)
Qiu Zhongling, Luo Quanyong （通讯作者） Coexistant Iodine-negative Pleura Metastasis with Iodine-positive Lung and Bone Metastases in a Same Differentiated Thyroid Cancer Patient. Clinical Nuclear Medicine 2009 34(11): 836-837(IF=4.278)
Qiu ZL, Luo QY.2009; 34(3): 137-140 （通讯作者） Erector Spinae Metastases from Differentiated Thyroid Cancer Identified by 131I-SPECT/CT. Clinical Nuclear Medicine 2009 34(3):137-140(IF=4.278)
Luo QY, Wang F, Zhang ZY, Guo YZ, Sun SH, Zhu RS. Preparation and bioevaluation of 99mTc-HYNIC-annexin B1 as a novel radioligand for apoptosis imaging Apoptosis 2008 13(4):600-608(IF=3.592)
Luo QY, Zhang ZY, Wang F, Sun SH, Zhu RS. Preparation, in vitro and in vivo evaluation of 99mTc-Annexin B1: A novel radioligand for apoptosis imaging. Biochemical and Biophysical Research Communications 2005 335(4):1102-1106(IF=2.371)